American Renal Associates Holdings Inc. (NYSE:ARA) shares shot up 4.8% on Monday . The company traded as high as $22.40 and last traded at $22.37, with a volume of 113,445 shares trading hands. The stock had previously closed at $21.35.

A number of brokerages recently weighed in on ARA. Leerink Swann began coverage on shares of American Renal Associates Holdings in a report on Monday, May 16th. They issued an “outperform” rating and a $33.00 price objective for the company. Goldman Sachs Group Inc. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “neutral” rating and a $30.00 price target for the company. Wells Fargo & Co. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating for the company. SunTrust Banks Inc. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “buy” rating and a $34.00 price target for the company. Finally, Barclays PLC initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “overweight” rating and a $33.00 price target for the company. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. American Renal Associates Holdings presently has an average rating of “Buy” and a consensus target price of $31.17.

The firm has a 50 day moving average of $23.85 and a 200 day moving average of $26.12. The company’s market capitalization is $679.40 million.

American Renal Associates Holdings (NYSE:ARA) last issued its quarterly earnings data on Tuesday, August 9th. The company reported ($0.75) earnings per share (EPS) for the quarter. The business had revenue of $185.60 million for the quarter, compared to the consensus estimate of $161.50 million. Analysts expect that American Renal Associates Holdings Inc. will post $0.96 earnings per share for the current fiscal year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.